Strong Wegovy revenue growth for Novo Nordisk but shares dip
Sales of the GLP-1RA hit $2.5bn in Q3, a 79% increase over the same period last year.
Sales of the GLP-1RA hit $2.5bn in Q3, a 79% increase over the same period last year.
What's Your Reaction?
